News|Videos|November 18, 2026

Pharmacists Can Address Diabetes Self-Management Barriers

Pharmacists can use CGM data to show patients how medications, physical activity, and lifestyle affect their blood glucose.

In an interview with Pharmacy Times, Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, senior vice president of medical affairs at the American Diabetes Association (ADA) and professor of pharmacotherapy at Washington State University College of Pharmacy and Pharmaceutical Sciences, discussed the message he most wants pharmacists to hear during Diabetes Awareness Month and how diabetes technology has changed the way pharmacists support patients day to day.

Key Takeaways

  • Address self-management barriers.
  • Support device use.
  • Teach using CGM data.

Neumiller noted that with over 40 million people living with diabetes in the US, pharmacists interact with these individuals daily, and many face self-management challenges, including barriers related to medication taking, monitoring, and access to therapies and technologies. He emphasized that pharmacists are well positioned across the health care system to address these challenges and provide ongoing education that improves care and outcomes.

On technology, Neumiller described advances ranging from continuous glucose monitors (CGMs), long used by people with type 1 diabetes and now increasingly by people with type 2 diabetes, to automated insulin delivery systems that ease the day-to-day burden of insulin management for people with type 1 diabetes. He called these technologies game changers and said pharmacists play a critical role in helping people use the devices effectively. In particular, CGM data allow pharmacists to show patients visually how medications, physical activity, lifestyle, and other factors affect their blood glucose, supporting meaningful self-management education.


Related to this article